The U.S.-Israel rift widens over Prime Minister Netanyahu's stance on Iran. Russia threatens to cut off gas supplies to Ukraine and Western Europe. And "Jihadi John" has been identified as a British national. A panel of journalists joins Diane for analysis of the week's top international news stories.
Guest Host: Susan Page
The makers of the antidepressant Prozac have come out with a new version of the drug that can be taken just once a week, but at the same time the patent on the formulation has expired. A panel talks about what Prozac has meant for American consumers, mental health professionals, and the pharmaceutical industry.
- Dr. Gary Tollefson Vice President of Lilly Research Laboratories, a division of Eli Lilly & Co.
- Dr. Peter Kramer Professor of Psychiatry at Brown University and author of "Listening to Prozac" and the novel "Spectacular Happiness."
- Sally Satel staff psychiatrist at the Oasis Clinic and fellow at the American Enterprise Institute
- Dr. Fred Goodwin research professor of psychiatry at George Washington University, former director of the National Institute of Mental Health, and host of the public radio's "The Infinite Mind"
Most Recent Shows
The clock is ticking as Congress races to fund the Department of Homeland Security. The House of Representatives considers a short-term funding bill to buy time before tonight’s midnight deadline. And in an historic vote, the Federal Communications Commission classifies broadband internet service as a public utility. A panel of journalists joins Diane for analysis of the week's top national news stories.
Tens of millions of Americans take nutritional supplements. New studies allege some pills do not contain what is on the label. Other research indicates consumers may be ingesting too many vitamins. New concerns about dietary supplements.
The next chapter in the battle over net neutrality: An expected new ruling from the FCC to regulate the Internet as a public utility.